CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
Condition: Synovial Sarcoma Interventions: Drug: Ramucirumab; Drug: Gemcitabine; Drug: Docetaxel Sponsor: Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials